未登录

A

Andrew S. Klein

Cedars Sinai Medical Center

H指数:40

被引数:6,616

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Factors Associated With Detection and Survival of T1 Hepatocellular Carcinoma in the United States: National Cancer Database Analysis

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2020-09-015

OA

Patients with severe acute-on-chronic liver failure are disadvantaged by model for end-stage liver disease-based organ allocation policy

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2020-07-2939

OAAI

Factors Associated with Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver Transplantation

GASTROENTEROLOGY

IF25.1

2019-04-01233

OAAI

Liver Transplant Survival Index for Patients with Model for End-Stage Liver Disease Score ≥ 35: Modeling Risk and Adjusting Expectations in the Share 35 Era

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

IF3.4

2019-04-019

PREAI

Regional Variation in Utilization and Outcomes of Liver Allografts From Donors With High Body Mass Index and Graft Macrosteatosis: A Role for Liver Biopsy

TRANSPLANTATION

IF5

2019-01-0112

OAAI

NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances

NASH导致女性肝移植的主要原因: 肝移植适应症和种族和性别差异的最新分析

AMERICAN JOURNAL OF GASTROENTEROLOGY

IF7.6

2018-11-01409

OAAI

Controversies in Early Liver Transplantation for Severe Alcoholic Hepatitis

ANNALS OF HEPATOLOGY

IF4.4

2018-09-0114

OAAI

Transplantation of Livers from High Body Mass Index Donors and the Impact of Hepatic Steatosis on Utilization and Outcomes: National and Regional Trends Over the Past Decade

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

IF3.4

2017-10-010

OAAI

The Braden Scale, A Standard Tool for Assessing Pressure Ulcer Risk, Predicts Early Outcomes After Liver Transplantation

LIVER TRANSPLANTATION

IF3.9

2017-08-2141

PREAI

Embolization of Portosystemic Shunts for Treatment of Medically Refractory Hepatic Encephalopathy

LIVER TRANSPLANTATION

IF3.9

2016-11-223

OAAI

Ibrutinib Suppresses De Novo Alloantibodies and Recall Antibody Responses in a Mouse Model of Allosensitization: A Preliminary Report

JOURNAL OF HEART AND LUNG TRANSPLANTATION

IF6

2016-04-010

OAAI

Alloantibody Suppression by Bruton Tyrosine Kinase Antagonist Ibrutinib Is Associated with Splenic B-Cell Reduction: A Study of Multiparameter Flow Cytometry

JOURNAL OF HEART AND LUNG TRANSPLANTATION

IF6

2016-04-010

PREAI

Obesity is independently associated with infection in hospitalised patients with end-stage liver disease

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2015-10-1325

OAAI

Donation After Cardiac Death Liver Transplantation in Primary Sclerosing Cholangitis: Proceed With Caution

TRANSPLANTATION

IF5

2015-05-0114

OAAI

CTLA4I9 Administered During T-Cell Priming Suppresses De Novo Alloantibodies and Minimizes Recall Antibody Responses

JOURNAL OF HEART AND LUNG TRANSPLANTATION

IF6

2015-04-010

OAAI

Anti-Interleukin 6 Receptor Antibodies Attenuate Antibody Recall Responses in a Mouse Model of Allosensitization

TRANSPLANTATION

IF5

2014-12-2756

OAAI

The impact of leadership styles on organizational culture and firm effectiveness: An empirical study

JOURNAL OF MANAGEMENT & ORGANIZATION

IF2.8

2013-12-1847

PREAI

Organ Donation and Utilization in the United States, 1999-2008

AMERICAN JOURNAL OF TRANSPLANTATION

IF8.2

2010-04-01273

OA

Flow cytometric isolation and phenotypic characterization of two subsets of ED2+(CD163) hepatic macrophages in rats

HEPATOLOGY RESEARCH

IF3.4

2009-11-3015

PREAI

A Revisit to the Pathogenesis of Allograft Fibrosis: Intragraft Fibroblasts Derive from Heterogeneous Progenitors

JOURNAL OF HEART AND LUNG TRANSPLANTATION

IF6

2009-02-010

PREAI